StartupHistory

An open directory of startups through time

Public records · dated sources
Free to read. Free to reuse.

Company records / pep2tango.com

Pep2Tango Therapeutics

Pep2Tango Therapeutics (pep2tango.com): no confident changes recorded yet; website history since February 2025. Homepage last checked 6 November 2026.

First recorded website

Observed 27 February 2025

Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.

How it described itself

Next generation anti-obesity unimolecular multi-agonist peptides with superior weight loss, preservation of muscle mass, and improved tolerability

Next generation anti-obesity unimolecular multi-agonist peptides with superior weight loss, preservation of muscle mass, and improved tolerability

All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.

Recorded changes

Newest observations first. Each interval bounds when the website changed; it is not an exact event date.

No changes recorded yet. Missing observations do not mean the company has not changed.

How it describes itself

Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.

  1. February 2025 – November 2026 · 2 captures · latest observed messagingNext generation anti-obesity unimolecular multi-agonist peptides with superior weight loss, preservation of muscle mass, and improved tolerability

    Next generation anti-obesity unimolecular multi-agonist peptides with superior weight loss, preservation of muscle mass, and improved tolerability

    This wording observed 6 November 2026.

    Inspect 2 captures in this group
    • 27 February 2025 · Next generation anti-obesity unimolecular multi-agonist peptides with superior weight loss, preservation of muscle mass, and improved tolerability archived page
    • 6 November 2026 · Next generation anti-obesity unimolecular multi-agonist peptides with superior weight loss, preservation of muscle mass, and improved tolerability current websiteHistorical capture not publicly available

Cite this record

StartupHistory, “Pep2Tango Therapeutics” company record, https://startuphistory.org/c/pep2tango.com

Machine-readable: /c/pep2tango.com.json. How changes are found: method.